J Clin Pathol Qual Control.  1999 Jun;21(1):13-22.

Annual Report on External Quality Assessment of Clinical Microbiology Laboratory in Korea (1998)

• Kim EC
• Kang JO
• Kim MJ
• Kim BC
• Kim SI
• Lee KW
• Lee DH
• Lee JH
• Lee NY
• Lee CK
• Shin CH
• Chang CH
• Choi HS

Abstract

Two trials of external quality assessment for clinical microbiology laboratory were performed in 1998. A total of ten specimens were distributed. Five specimens were distributed to 430 laboratories with 193 returns in Trial I and five specimens to 209 laboratories with 192 returns in Trial II. The percentages of fully correct identification of S. aureus, E. coli, E. faecalis, P. aeruginosa, S. saprophyticus, E. coli, S. marcescens, P. aeruginosa and L. monocytogenes were 95.9%, 99.0%, 66.3%, 59.9%, 97.9%, 93.2%, 96.9%, and 68.2%, respectively. The acceptable percentages on disk-diffusion antibacterial susceptibility tests against oxacillin and vacomycin of S. aureus (MB9801) in Trail I were 75.7% and 56.8%, respectively. Those against ampicillin and gentamicin of E. coli (MB9802) were 87.9% and 84.3%, respectively. Those against ampicillin and vancomycin of E. faecalis (MB9803) were 96.2% and 48.0%, respectively. Those against piperacillin and tobramycin of P. aeruginosa (MB9804) were 68.5% and 84.8%, respectively. In Trail II, the performance on antimicrobial susceptibility showing 88.1% - 100% as acceptable percentages was improved except that (76.1%) against piperacillin of P. aeruginosa.

MeSH Terms

Ampicillin
Gentamicins
Korea*
Oxacillin
Piperacillin
Tobramycin
Vancomycin
Ampicillin
Gentamicins
Oxacillin
Piperacillin
Tobramycin
Vancomycin